Major AI-Pharma Partnerships And Investments Of 2024: A Strategic Overview

 
• By David Wild

In Vivo looks at the top partnerships and investments in AI-driven companies in 2024. Collaborations and investments spanned multiple therapeutic areas, with a particular focus on small molecule discovery, protein degradation and neurological diseases.

(Shutterstock)

More from Deal-Making

More from Business Strategy